Heres a look at what the drug industry is paying to put on your screen this Sunday, despite the FDAs vocal criticism
This presents a significant challenge in the design of clinical trials, as they must be sufficiently long-term to accurately assess the true benefits and potential adverse effects of CHM, while also being feasible in terms of resources and patient compliance
Wegovy is approved by the FDA for weight loss in overweight and obese individuals whereas Ozempic is only approved to treat Type-2 diabetes
Discontinuation typically results in weight regain within 612 months if diet and activity patterns revert
At the FDA, he serves as a Subject Matter Expert in multiple regulatory and scientific working groups and as a Government Liaison to the USP Expert Committee on Biologics Monographs 1 Peptides, Oligonucleotides, and Complex Carbohydrates
[2] This is not a minor administrative issue